(2/3) Congratulations to Ines García, @crismayorruiz.bsky.social and all the contributors from the @irbbarcelona.org and from CIC Salamanca behind the recently published in the “Cancer Research” journal @aacrjournals.bsky.social: doi.org/10.1158/0008...
Abstract. Recent drug discovery breakthroughs led to the approval of KRASG12C inhibitors in lung adenocarcinoma (LUAD). Unfortunately, clinical responses are often hampered by the rapid resistance ons...
